Your best source on healthcare and wellness news from Germany
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
Press releases
Publish your press release
2 hours ago
Global Environmental Health and Safety Software Market Size/Share Worth USD 14.52 Billion by 2035 at a 7.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Environmental Health and Safety Software Market Size, Trends and Insights By Deployment Mode (Cloud-Based, Public Cloud, Private...
![[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/99b3f70b-ffc1-4e20-b3d6-a7391fcbaa8f/north-america-targeted-dna-rna-sequencing-market-size-2025-to-2035-usd-billion-.png)
15 hours ago
[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS, Method, Exome Sequencing, Enrichment Sequencing,...
17 hours ago
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
GlobeNewswire, Inc.
New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The hepatic encephalopathy market is expected to...
May. 4, 2026
CDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results
GlobeNewswire, Inc.
Tarrytown, NY, USA, May 04, 2026 (GLOBE NEWSWIRE) -- The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT Certification Certification reaffirms assay results are aligned with specialized mass spectrometry testing method...
May. 4, 2026
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
GlobeNewswire, Inc.
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, post-prandial fullness and...
May. 4, 2026
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
GlobeNewswire, Inc.
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, post-prandial fullness and...
Video Stories
Sign up for German Health Review.
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
